Are We Fighting Cancer Wrong?

Dr. Sunitha Nagrath and Dr. Tae Hyun Kim featured internationally for the development of Indwelling CTC Device

"A new device is capable of screening blood that captures 3.5 times the number of cancer cells as the current method, according to new findings published Monday in Nature Communications. This new device, which was tested in lab animals, may be able to better diagnose and treat humans with cancer. The new device continuously screens blood over the course of a few hours, straight from a person's vein. This will allow more of their blood to be tested, which will increase the chances of catching cancer cells."

"It's the difference between having a security camera that takes a snapshot of a door every five minutes or takes a video. If an intruder enters between the snapshots, you wouldn't know about it," said Sunitha Nagrath, a researcher at University of Michigan and lead developer of the device.

— United Press International

Read the entire article on United Press International.

Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early Stage Lung Cancers
Lab Member Vasudha Murlidhar published in Cancer Research (2017)
High-Throughput Microfluidic Labyrinth for the Label-free Isolation of Circulating Tumor Cells
Lab Members Eric Lin and Lianette Rivera-Báez published in Cell Systems (2017)

Are We Fighting Cancer Wrong?

Professor Nagrath featured in Michigan Engineering Article

"Nagrath works closely with Wicha and other Michigan oncologists to design chips that can capture and handle cancer cells in different ways, for different purposes. One of her recent projects with Nithya Ramnath, an associate professor of medical oncology, studied whether circulating tumor cells captured from blood could monitor the progression of lung cancer as well as biopsies, which typically involves removing samples from the tumor with a large needle."

We proposed an idea — a really bold idea — that we take cancer cells from these patients through blood samples. We culture the cells, and we treat these cultures with the same drugs that she’s administering to the patients in the clinic.

— Professor Sunitha Nagrath

Read the entire article on Medium.